The purpose of this study is to examine clinical and neuropsychiatric effects of Korean Red Ginseng and examine changes in brain structure, function and metabolites. A total of 60 healthy volunteers will be recruited and will be assigned to either Korean Red Ginseng group or placebo group. Individuals will be examined through clinical assessment, neuropsychological function tests and neuroimaging.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
51
Korean Red Ginseng Capsule (1g/day) for 8 Weeks
Placebo Capsule (1g/day) for 8 Weeks
Seoul National University Hospital
Seoul, South Korea
Change from Baseline in Stress Scores at 8 Weeks
Time frame: Baseline and 8 Weeks
Change from Baseline in Stress Scores at 4 Weeks
Time frame: Baseline and 4 Weeks
Change from Baseline in Stress Scores at 1 Week
Time frame: Baseline and 1 Week
Change from Baseline in Neurocognitive Function at 8 Weeks
Time frame: Baseline and 8 Weeks
Change from Baseline in Brain Function, Chemistry, and Structure Measured Using Magnetic Resonance Imaging at 8 Weeks
Time frame: Baseline and 8 Weeks
Change in Fatigue Scores at 8 Weeks
Time frame: Baseline and 8 Weeks
Change in Fatigue Scores at 4 Weeks
Time frame: Baseline and 4 Weeks
Change in Fatigue Scores at 1 Week
Time frame: Baseline and 1 Week
Change in Depressive Scores at 8 Weeks
Time frame: Baseline and 8 Weeks
Change in Depressive Scores at 4 Weeks
Time frame: Baseline and 4 Weeks
Change in Depressive Scores at 1 Week
Time frame: Baseline and 1 Week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in Anxiety Scores at 8 Weeks
Time frame: Baseline and 8 Weeks
Change in Anxiety Scores at 4 Weeks
Time frame: Baseline and 4 Weeks
Change in Anxiety Scores at 1 Week
Time frame: Baseline and 1 Week
Number of Participants Who Experienced Adverse Events
Time frame: Week 1
Number of Participants Who Experienced Adverse Events
Time frame: Week 4
Number of Participants Who Experienced Adverse Events
Time frame: Week 8